Evidence map›Paper›PMID 41077698›Full record

ArticleBritish journal of haematology2025

Primary CD34

Daniel Nowak, Marie Demmerle, Alessa Klär, Alexander Streuer, Vladimir Riabov, Eva Altrock, Felicitas Rapp, Ann-Christin Belzer, Teresa Klink, Meret Hahn and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Daniel NowakDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Marie DemmerleDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Alessa KlärDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Alexander StreuerDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Vladimir RiabovDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID https://orcid.org/0000-0001-5689-5681
Eva AltrockDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Felicitas RappDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Ann-Christin BelzerDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Teresa KlinkDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Meret HahnDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Franziska HofmannDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Verena NowakDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Nadine WeimerDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Julia ObländerDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Iris PalmeDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Melda GölDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Ali DarwichDepartment of Orthopedic Surgery, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Laurenz SteinerDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Mohammed AbbaDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Georgia MetzgerothDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Wolf-Karsten HofmannDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Nanni SchmittDepartment of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.ORCID https://orcid.org/0000-0003-3455-9606

Funding

Bundesinstitut für Risikobewertung 60-0102-01.P638-12710524Deutsche Krebshilfe 70113953Dr. Werner Jackstädt-StiftungForum Gesundheitsstandort Baden-Württemberg BW 4-5400/136/1German Research Foundation SFB 1709/1 2025-533056198Health + Life Science Alliance Heidelberg Mannheim MWK32-7531-26/8/2Medical Faculty Mannheim, Heidelberg UniversityTorsten Haferlach Leukämiediagnostik Stiftung 143/235/80937
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MDSpevonedistatTAK‐243VEXAS syndrome

Identifiers

PMID41077698
PMCPMC12710189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.